These Fundamentals Suggest that Microsoft (NASDAQ:MSFT) Investors might be Overpaying on the Stock

What trends should we look for if we want to identify stocks that create value over the long term? We'd want to identify a growing return on capital employed (ROCE), an ever-increasing base of capital employed, and finally a cost of capital lower than the return. This shows us that the company is continually reinvesting its earnings back into the business and generates higher returns. So, here is what we found when we looked at the ROCE trend of Microsoft (NASDAQ:MSFT).

Advertisement

Understanding Return On Capital Employed (ROCE)

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. Analysts use this formula to calculate it for Microsoft:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.29 = US$70b ÷ (US$334b - US$89b) (Based on the trailing twelve months to June 2021).

So, Microsoft has an ROCE of 29%. In absolute terms that's a great return and it's even better than the Software industry average of 10.0%.

Check out our latest analysis for Microsoft

roce
NasdaqGS:MSFT Return on Capital Employed September 15th 2021

In the above chart we have measured Microsoft's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free report for Microsoft.

So How Is Microsoft's ROCE Trending?

In the last five years, the returns generated on capital employed have grown from 17%, considerably to 29%. This implies that management is investing in some better projects and acquisitions.

The company is effectively making more money per dollar of capital used than it did three years ago, and it's worth noting that the amount of capital has increased too, by 82%.

Microsoft's Cost of Capital

When looking at the returns on capital employed, we get a better sense of the quality of the metric by comparing it to the cost of capital. If the return is greater than the cost, then we can argue that the company is creating value by making smart moves.

The cost of capital for Microsoft is 6.4%. Which is quite smaller than the return of 29%. This means that the company is creating excess returns of 22.6%!

This shows investors that the company is picking the right projects and maximizing their value. Further, this implies that the company has not exhausted its growth capacity and has room to sustain high growth rates before hitting full maturity - This is usually when the cost of capital converges to the return on capital and the company has difficulties finding profitable projects (or acquisitions). 

For those that wonder what is the cost of capital and how we get it, here is the rough explanation. The cost of capital is the weighted average of the cost for the company to raise funds from both equity investors and lenders.

Weighted by what? Weighted by the market value of the equity in the company and the market value of the debt.

Great, now what is the cost of equity and the cost of debt?

The cost of equity is the return (in gains and dividends) that a company must offer investors for them buying the stock. Put simply, if the cost of equity is 7%, then MSFT's fundamentals need to have a basis to deliver at least 7% gains for you (the investor buying their stock).

Conversely, the cost of debt is the return a company needs to promise banks in order to secure loans or bond purchases. The cost of debt is the rate at which the company can borrow long term TODAY (not in the past). One major component of the cost of debt is the long term interest rate of the economy (a.k.a. the risk-free rate), which is why investors fear inflation - if the rates rise, so will the cost of debt jump for companies, and they will have fewer opportunities to raise cheap debt or to refinance existing obligations.

Now we have a better picture as to why the returns that are above the cost of capital create value, and returns that are lower than this, destroy value for shareholders. Therefore, Microsoft is a value creator by a large margin (21.6%)!

Implications for Company Value

With that being said, we use the free cash flows to equity investors to see if their sum, and their value in perpetuity, is worth the cost to buy MSFT shares. This is known as valuation and in our rough model we can see that MSFT is valued at US$417 per share, suggesting that the company is 28% undervalued.

Alternatively, if we take the cost of capital as an indicator, instead of just the cost of equity we get a different picture and value the company with a Free Cash Flow to Firm model at US$267 per share, implying that the company is overvalued by 12%.

Unfortunately, determining the intrinsic value of a company is complicated and there are rarely simple answers. Valuation relies on multiple assumptions about growth, profitability, risk, returns relative to costs, and interest rates as part of the cost of capital. But knowing the range of possibilities will help investors make better decisions in the market.

Key Takeaways

To sum it up, Microsoft has proven it can reinvest in the business and generate higher returns on that capital employed, which is terrific. And a remarkable 461% total return over the last five years tells us that investors are expecting more good things to come in the future.

Microsoft is still a value creating company, with the return on capital employed (29%) surpassing the cost of capital (6.4%).

The implication for value is a bit divergent. Best case - the stock is undervalued by 28%, and worst case, investors are overpaying by 12% for buying Microsoft shares.

On a separate note, we've found 2 warning signs for Microsoft you'll probably want to know about.

If you want to search for more stocks that have been earning high returns, check out this free list of stocks with solid balance sheets that are also earning high returns on equity.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Simply Wall St analyst Goran Damchevski and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Goran Damchevski

Goran Damchevski

Goran is an Equity Analyst and Writer at Simply Wall St with over 5 years of experience in financial analysis and company research. Goran previously worked in a seed-stage startup as a capital markets research analyst and product lead and developed a financial data platform for equity investors. 

About NasdaqGS:MSFT

Microsoft

Develops and supports software, services, devices, and solutions worldwide.

Very undervalued with outstanding track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
51 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4849.2% undervalued
205 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43038.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9956.4% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

ON
LOT logo
Ontological on Lotus Technology ·

Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization

Fair Value:US$2.463.9% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
NE
AIIO logo
newsfinder11221 on Robo.ai ·

Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution

Fair Value:US$540.4% undervalued
1 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
ALMIN logo
European_Hidden_Gem_Stocks on MINT Société anonyme ·

Mint SA: A French Micro-Cap Energy Retailer Worth Watching

Fair Value:€1153.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
88 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
199 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0